Home/Blog/Science
Science·20 min read

The Slow Glue: How Sugar Hardens Everything It Touches

BD

Dr. Barry Dublin, MD

July 1, 2026

A Spoonful of Sugar Makes the Mitochondria Go Down

Part 5 of 7 — The Slow Glue: How Sugar Hardens Everything It Touches

So far in this series I have shown you the fire — the spectacular, fast-moving cellular damage that happens when sugar overwhelms the mitochondrial machinery. The sparks. The hydroxyl radicals. The cardiolipin burning. The mtDNA mutations.

In this chapter I want to show you something quieter. A second campaign of damage that runs entirely in parallel to the mitochondrial one, that requires no overload, no enzyme, no special pathway. A campaign that operates merely by sugar's presence in your bloodstream, given enough time. It is the reason that diabetic blood vessels harden, diabetic kidneys scar, diabetic eyes go cloudy, and diabetic nerves slow down. It is the reason that elderly skin loses its elasticity, that muscle gets stiffer with age, and that arteries become rigid pipes.

It is called glycation, and the end products of it are called AGEs — Advanced Glycation End-products. The acronym is fitting. Sugar is, in the most literal sense, aging you.


What Glycation Is

Picture a long protein molecule floating in your bloodstream. Hemoglobin, say — the protein in red blood cells that carries oxygen. Or collagen — the structural protein that gives your skin its elasticity, your blood vessels their flexibility, your ligaments their strength, and your bones their resilience. Or albumin — the workhorse transport protein in your blood. All of these proteins have, hanging off their sides, certain reactive chemical groups called amino groups. Think of them as the velcro tabs on a zipper.

Now picture a glucose molecule floating past. Glucose has a reactive end of its own. When the glucose and the protein happen to bump into each other in the right orientation, they stick. No enzyme is required. No regulation occurs. The sticking just happens, randomly, as a function of how much glucose is around and how often the collisions happen.[1][2]

This sticking process is called glycation. The initial attachment is a relatively weak, reversible bond called a Schiff base. Over hours, the Schiff base rearranges into a more stable structure called an Amadori product. And over days, weeks, months, the Amadori product undergoes a series of further chemical reactions — oxidation, cross-linking, rearrangement — and eventually becomes a permanently fused, chemically altered protein. An AGE.[1][90]

The AGE is no longer the protein it started as. It does not work the way the original protein worked. And it cannot be easily broken down by the cell's protein-recycling machinery, which is calibrated to recognize and process normal proteins, not glycated freaks. So the AGE accumulates. It sits there. And it slowly destroys the function of whatever tissue it is in.

Think of it as superglue. Slow superglue. Over years, glucose molecules in your bloodstream are slowly, randomly, permanently gluing your structural proteins together — and gluing them into shapes they were never supposed to be in.


Hemoglobin A1c: The Smoking Gun You Already Know About

You may not have realized it, but you have already met an AGE. Every diabetic in the world knows the blood test called HbA1c — hemoglobin A1c. The HbA1c level is the percentage of your hemoglobin that has been glycated. It is, literally, a measure of how much sugar has been gluing itself to the oxygen-carrying protein in your red blood cells over the past three months.[82][83]

A non-diabetic person has an HbA1c around 4.5 to 5.6 percent. Pre-diabetic, 5.7 to 6.4. Diabetic, 6.5 or above. Each percentage point of HbA1c corresponds, roughly, to an average blood glucose level over the previous three months. Higher A1c means higher average glucose, which means more glycation, which means more permanent damage being done to every protein in your body. The HbA1c is just the easiest one to measure; it is a proxy for everything else.

When a diabetes specialist tells a patient to "get your A1c under seven," they are essentially saying: please slow down the rate at which your sugar is gluing your proteins into dysfunctional shapes. That is what is being measured. That is what is being slowed.

But here is the thing. The glycation reaction occurs in everyone, not just diabetics. It is just slower in people with lower blood sugar. A non-diabetic with an HbA1c of 5.4 is still glycating proteins, just at a lower rate. The damage accumulates over decades. And when you eat sugar — especially in the form of post-meal spikes that drive your transient glucose up over 150 milligrams per deciliter — the rate of glycation accelerates dramatically during those windows. Repeated daily spikes, over years, do meaningful cumulative damage even in someone whose fasting glucose looks "fine" on the annual physical.


The Slow Damage: Where AGEs Hit

The body is built from proteins. The proteins are vulnerable to glycation in proportion to how slowly they turn over — how long they sit in place before being replaced. Proteins that turn over rapidly (the enzymes inside cells, for example) get replaced before substantial AGE damage accumulates. But proteins that last for years, or even for a lifetime, accumulate AGEs continuously the entire time they are in your body. Those long-lived proteins are the foundational structural materials of the body itself: the collagen in your skin, the collagen and elastin in your arteries, the proteins of the lens of your eye, the proteins of the cartilage in your joints, the myelin in your nerves, the matrix proteins of your kidneys.

Let me walk you through the consequences.

The arteries. Collagen and elastin are the structural proteins that give your arteries their flexibility — the slight elastic give that lets the artery wall expand with each heartbeat and recoil between beats, smoothing out blood pressure and protecting the small vessels downstream. When AGEs crosslink collagen and elastin in the artery wall, the artery becomes stiffer. It loses its give. The crosslinks act like little molecular rivets, locking the protein fibers into a rigid lattice. The artery turns from a flexible hose into something closer to a copper pipe. The clinical consequence is what cardiologists call arterial stiffness — and it is the foundation of essential hypertension, the development of atherosclerosis, and the failure of the small vessels in the kidneys, retina, and brain. A patient walks into your office with high blood pressure that they "developed in their fifties." What they actually developed was forty years of accumulated AGE damage to their arterial walls.[1][22][86]

The kidneys. The filtering apparatus of the kidney — the glomeruli — consists of delicate membranes that filter blood through a precise structural protein matrix. When AGEs accumulate in the glomerular membrane, the membrane thickens and scars. Filtration becomes inefficient. Protein begins leaking into the urine. This is diabetic nephropathy, and it is the leading cause of end-stage kidney disease worldwide. Every year, thousands of people start dialysis because the AGE damage in their kidney filters has progressed beyond the point of function.[20]

The eyes. The lens of your eye is made of proteins that, uniquely, are never replaced. The lens proteins you were born with are the lens proteins you die with. Over a lifetime, glycation slowly attacks them. The proteins crosslink. The crosslinks scatter light. The lens loses transparency. This is a cataract. Every person develops cataracts eventually because every person glycates lens proteins eventually — but cataracts in diabetics develop earlier, faster, and worse. Meanwhile, in the retina at the back of the eye, AGE damage to the tiny blood vessels causes them to leak, scar, and proliferate abnormally. This is diabetic retinopathy, the leading cause of blindness in working-age adults.

The nerves. The myelin sheath that insulates your nerve fibers is a protein-and-lipid structure that, like the lens, has very slow turnover. When AGEs accumulate in myelin, the insulation becomes less effective. Nerve impulses travel more slowly. Sensory perception dulls — first in the feet, where the nerves are longest. The diabetic patient who can no longer feel a coin under their bare foot has not lost the nerves; the nerves have just been progressively glycated to dysfunction. This is diabetic peripheral neuropathy. It is the reason diabetics get unhealed foot ulcers and amputations. It begins decades before the symptoms appear, in patients whose blood sugar is high but who don't yet feel anything wrong.

The skin. Collagen and elastin in skin are crosslinked by AGEs the same way they are in arteries. Skin loses elasticity. Wrinkles deepen. The face of a chronically high-sugar-eating sixty-year-old shows damage that a chronically low-sugar-eating sixty-year-old will not have for another fifteen years. The cosmetic version is wrinkles; the medical version is impaired wound healing, the failure of skin to repair after injury, and the slow progressive thinning of older skin into something that bruises and tears easily. The same biology is doing both.

Muscle. In human skeletal muscle biopsies comparing young adults to elderly adults, the AGE marker pentosidine in muscle connective tissue is approximately three times higher in the elderly group than in the young group. That is a measurable, quantitative record of decades of accumulated glycation slowly degrading muscle function and force transmission. It is one of the molecular reasons that muscle is harder to build, easier to lose, and slower to recover with age.


RAGE: The Receptor That Makes It Worse

AGEs do not just sit there as inert glue. The body, recognizing them as abnormal, has evolved a receptor specifically for AGEs. The receptor is called RAGE — Receptor for Advanced Glycation End-products. (Yes, the name is unfortunate. Yes, it makes the acronym easy to remember.)

When AGEs in the bloodstream encounter cells expressing RAGE — and many cells do, including cells of the blood vessel wall, immune cells, and brain cells — binding occurs, and that binding triggers a cascade of intracellular signaling. The end of the cascade is the activation of a master inflammation switch called NF-κB.[12][50][51]

NF-κB is a transcription factor — a protein that moves into the cell nucleus and turns on genes. When NF-κB is activated, it turns on the genes for inflammatory cytokines. Over two hundred of them. Simultaneously. The cell, in response to AGE-RAGE binding, becomes a tiny inflammation factory, broadcasting signals that tell every immune cell in the neighborhood: something is wrong here, come and look.

This is one of the molecular roads by which chronic high blood sugar produces chronic systemic inflammation. It is not subtle. You can measure it. The standard clinical marker is high-sensitivity C-reactive protein, or hs-CRP — a blood test your doctor can order. People with metabolic syndrome and chronic high sugar exposure routinely have hs-CRP levels that are three to ten times higher than people without those conditions.[84][85][86][87]

And inflammation is the lubricant on which most of modern chronic disease runs. It is what propels atherosclerosis. It is what makes joints painful in osteoarthritis. It is what drives the gradual destruction of the pancreatic beta cells in type 2 diabetes. It is what slowly damages the neurons in Alzheimer's disease. The inflammation isn't a side effect of the chronic disease — in many cases, it is the central engine.

And the sugar in your morning coffee, the juice in your kid's school lunchbox, the smoothie your mother makes for breakfast, the cereal that comes in a box marketed as healthy — these are not innocent. They are pouring kerosene on a fire that is, in most modern adults, already burning.


Why AGEs Are Permanent

The most painful feature of AGE damage is that, for the most part, it is not reversible. Once a protein has been irreversibly cross-linked by sugar — once it has progressed past the early Schiff-base and Amadori stages into a true AGE — the damage stays. The cell cannot un-glue what has been glued.

What the cell can do is replace the damaged protein with a fresh one — but only for proteins that turn over. Hemoglobin, for example, lives only about ninety days. Glycated hemoglobin is replaced as red blood cells are destroyed and rebuilt. This is why your HbA1c can improve over three months if your blood sugar improves.

But the long-lived proteins — lens crystallins, arterial collagen, myelin, kidney glomerular membranes — turn over very slowly, or not at all. The AGEs in those tissues are essentially with you for life. You can stop adding new ones by getting your blood sugar under control. But you can't easily remove the ones that are already there.

This is one of the molecular reasons why the disease consequences of long-term high sugar — diabetic retinopathy, neuropathy, nephropathy, atherosclerosis — tend to be partially irreversible even after a patient achieves excellent blood sugar control later in life. The fire can be put out. The damage already done cannot all be undone.

This is, again, the case for prevention. The damage you do not do is the damage that does not need to be reversed.


Dietary AGEs: A Smaller, but Real, Issue

There is one more piece of the AGE story worth mentioning, because it is often confused in popular nutrition writing.

In addition to the AGEs your body produces internally from its own glucose, there is a separate category of AGEs called dietary AGEs — the AGEs that form in food when food is cooked at high temperatures. When you grill a steak and the surface gets that brown, charred crust, much of what you are looking at is AGEs that formed during the cooking process. The same is true of toasted bread, of seared meat, of any food cooked at high temperature, especially in the presence of sugar. The "Maillard reaction" that gives charred and browned food its flavor is essentially the same chemistry as the glycation that happens inside your bloodstream.

When you eat dietary AGEs, some fraction of them survive digestion and enter your circulation. They contribute to your total AGE load, though the contribution is generally smaller than the AGEs your body produces internally from its own blood sugar.

The practical takeaway: high-heat cooking, charring, deep-frying, and especially the combination of high heat plus sugar (the brown crust on a baked dessert, for example, or the caramelization on a glazed donut) increases your dietary AGE intake. The bigger driver, however, is still your own blood sugar. You can dramatically reduce your AGE load by reducing your blood glucose; you cannot dramatically reduce it just by avoiding charred food while continuing to spike your blood sugar all day.


The Combined Picture So Far

Let me pause and assemble what we now have on the table.

Through Parts 2 and 3, we have established that excess glucose overwhelms the electron transport chain, generating sparks (superoxide), which generate hydroxyl radicals (with help from leaked iron and accumulated hydrogen peroxide), which burn the cardiolipin scaffolding, which destabilize the ETC complexes, which generate more sparks, which damage mtDNA, which corrupts the blueprint for new mitochondrial proteins, which compounds the failure across generations of mitochondria. The mitochondrial death cascade.

Through Part 4, we have established that excess fructose hits the liver, depletes ATP, generates uric acid, blocks AMPK, fires off a second non-mitochondrial source of superoxide, and converts the liver's metabolic state into one that synthesizes fat. The fructose truth.

Now in Part 5, we have established a third parallel campaign: glucose, simply by floating in the bloodstream, is slowly gluing your structural proteins into dysfunctional shapes, accumulating year after year, and triggering chronic systemic inflammation through RAGE-mediated NF-κB activation. The slow glue.

These three campaigns operate simultaneously. They are not alternatives. They are coordinated assaults, running in parallel, on different timescales. And the cumulative effect of a lifetime of modern sugar consumption is the cumulative effect of all three at once.


The Inflammasome and the Cytokine Cascade

There is one more piece I owe you, because it bridges Parts 3 through 5 into what comes next.

Inside immune cells — and increasingly recognized in many other cell types — there exists a multi-protein machine called the NLRP3 inflammasome. The inflammasome is essentially the cell's smoke detector and grenade launcher, combined into one unit. It is designed to detect signs of cellular distress and, when it detects them, to release powerful inflammatory signals to alert the rest of the body.[31][32][34][35][36]

The inflammasome is activated by a remarkable variety of "danger" signals: bacterial fragments, viral components, crystalline materials like uric acid or cholesterol crystals, mitochondrial DNA that has escaped from damaged mitochondria, and — critically — reactive oxygen species working through a regulatory molecule called TXNIP.

Here is what happens when chronic high glucose activates the inflammasome:[37][38][39]

The mitochondrial ROS we discussed in Part 3 activate TXNIP. TXNIP triggers the assembly of NLRP3 proteins into a multi-unit ring. The ring recruits a connector protein (ASC), which recruits an inactive enzyme (pro-caspase-1). Multiple pro-caspase-1 molecules activate each other into active caspase-1, which cuts the precursor forms of two inflammatory signaling molecules — IL-1β and IL-18 — into their active forms. Caspase-1 also cuts a protein called gasdermin D, which migrates to the cell membrane and punches holes through it. The IL-1β and IL-18 stream out of the holes. Eventually, the cell ruptures completely, in a form of inflammatory cell death called pyroptosis.[33]

Once IL-1β and IL-18 reach the surrounding tissue, they activate more immune cells, which infiltrate the tissue, which produce more cytokines — TNF-α, IL-6, IL-8, MCP-1 — which travel through the bloodstream and trigger inflammatory responses in distant tissues, which raise the liver's production of CRP, which the doctor measures and tells you is "a marker of inflammation."

In type 2 diabetes — and in the wounds of diabetic patients — researchers have measured significantly elevated NLRP3 expression, elevated caspase-1, and elevated IL-1β, compared to non-diabetic controls.[34][39] The inflammasome is, in real diabetic tissue, in real human patients, demonstrably active. The chronic, low-grade, body-wide inflammation that we measure in metabolic syndrome is real, and it is mechanistically linked through these molecular pathways to the sugar exposure.

This matters because, in Part 6, we are going to see how this inflammation directly disables the insulin signaling system at the cell membrane. The cytokine cascade triggered by sugar damage is the molecular tool that cuts the insulin relay cable. It is the bridge between the cellular damage we have been describing and the systemic disease of insulin resistance and type 2 diabetes.


Where We Are Going

In Part 6, we follow the chain to its end. We watch the inflammation produced by sugar's various campaigns of damage activate the inflammatory kinases — JNK, IKKβ — that physically modify the insulin signaling proteins inside cells. We watch the relay cable get cut. We watch glucose pile up in the blood while cells starve. We watch the brain begin to fail, slowly, despite blood glucose levels that look fine on paper. We see the link between sugar and dementia made explicit.

And then, in Part 7, we get to what matters most: the plan. What I do for my patients. What works. How recoverable the damage is, and at what stages. What numbers a serious person can aim for, and what numbers indicate that the recovery has begun.

The story is two-thirds told. Stay with me. The most actionable part is still ahead.

Ready to Take Control of Your Metabolic Health?

If you're ready to stop the damage and start repairing your cellular engines, our coaching program can help you implement these principles in your daily life.

Free Download: The Mitochondrial Toxin Reference Guide

Download our comprehensive guide to identifying and avoiding common mitochondrial toxins in your environment and diet.

Download PDF

References

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813-820. https://doi.org/10.1038/414813a

2. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615-1625. https://doi.org/10.2337/diabetes.54.6.1615

12. Ma X, Nan F, Liang H, et al. Excessive intake of sugar: an accomplice of inflammation. Front Immunol. 2022;13:988481. https://pmc.ncbi.nlm.nih.gov/articles/PMC9471313/

20. Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol. 2017;13(10):629-646. https://pmc.ncbi.nlm.nih.gov/articles/PMC5858653/

22. Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med. 2005;38(10):1278-1295. https://doi.org/10.1016/j.freeradbiomed.2005.02.014

31. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417-426. https://doi.org/10.1016/S1097-2765(02)00599-3

32. Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477-489. https://pmc.ncbi.nlm.nih.gov/articles/PMC7807240/

33. Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660-665. https://doi.org/10.1038/nature15514

34. Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179-188. https://pmc.ncbi.nlm.nih.gov/articles/PMC3076025/

35. Wen H, Gris D, Lei Y, et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol. 2011;12(5):408-415. https://pmc.ncbi.nlm.nih.gov/articles/PMC3107920/

36. Youm YH, Grant RW, McCabe LR, et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 2013;18(4):519-532. https://pmc.ncbi.nlm.nih.gov/articles/PMC3835693/

37. Wang Y, Zhang C, Zhang P, et al. Acute glucose shift induces the activation of the NLRP3 inflammasome in THP-1 cells. Int J Mol Sci. 2021;22(18):9952. https://pmc.ncbi.nlm.nih.gov/articles/PMC8465199/

38. Bhatt NP, et al. High glucose and LPS prime NLRP3 inflammasome via ROS/TXNIP pathway for therapeutic targeting in diabetic nephropathy. Front Pharmacol. 2016. https://pmc.ncbi.nlm.nih.gov/articles/PMC4736396/

39. Zhang Y, et al. High glucose mediates NLRP3 inflammasome activation via upregulation of ELF3 expression. Cell Death Dis. 2020. https://doi.org/10.1038/s41419-020-2598-6

50. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118(9):2992-3002. https://pmc.ncbi.nlm.nih.gov/articles/PMC2522355/

51. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793-1801. https://pmc.ncbi.nlm.nih.gov/articles/PMC1483173/

82. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ. 2001;322(7277):15-18. https://doi.org/10.1136/bmj.322.7277.15

83. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ. 2000;321(7258):405-412. https://doi.org/10.1136/bmj.321.7258.405

84. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. Arterioscler Thromb Vasc Biol. 1999;19(4):972-978. https://doi.org/10.1161/01.atv.19.4.972

85. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973-979. https://doi.org/10.1056/NEJM199704033361401

86. Dandona P, Aljada A, Chaudhuri A, et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111(11):1448-1454. https://doi.org/10.1161/01.CIR.0000158483.13093.9D

87. Festa A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102(1):42-47. https://doi.org/10.1161/01.cir.102.1.42

90. Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev. 2005;1(3):287-298. https://doi.org/10.2174/157339905774574383

BD

About the Author

Exploring the deep mechanics of cellular health, mitochondrial function, and metabolic disease.